MEDICAMEN BIOTECH LTD.

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	122.6	111.51	82.46	67.34	78
Other Income	3.66	1.89	0.31	0.7	1.1
Stock Adjustments	-1.39	1.13	-0.99	-1.02	0.33
Total Income	124.87	114.53	81.78	67.02	79.43
EXPENDITURE :
Raw Materials	81.95	68.78	48.22	41.79	52.08
Excise Duty	0	0	0	0.06	0.21
Power and Fuel Cost	2.11	2.78	2.35	2.76	3.29
Other Manufacturing Expenses	5.95	8.67	5.39	3.3	3.2
Employee Cost	8.09	9.05	6.65	4.86	5.42
Selling and Administration Expenses	5.11	6.41	7.12	7.23	8.13
Miscellaneous Expenses	0.54	0.16	0.15	0.78	0.96
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	21.12	18.67	11.89	6.23	6.14
Interest and Financial Charges	1.38	2.71	3.61	3.62	3.92
Profit before Depreciation and Tax	19.74	15.96	8.28	2.61	2.22
Depreciation	2.21	2.06	1.92	1.9	2.1
Profit Before Tax	17.53	13.9	6.36	0.71	0.12
Tax	5.5	3.79	1.2	0.23	-0.32
Profit After Tax	12.03	10.11	5.16	0.48	0.44
Adjustment below Net Profit	0	0	0	0	-0.48
P and L Balance brought forward	19.74	10.96	6	5.32	5.36
Appropriations	0	1.33	0	0	0
P and L Bal. carried down	31.77	19.74	11.16	5.8	5.32
Equity Dividend	0	1.33	0	0	0
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0	0
Equity Dividend (%)	10	10	0	0	0
Earning Per Share (Rs.)	10.28	8.64	4.91	0.48	0.46
Book Value	74.05	63.77	24.73	17.92	17.77
Extraordinary Items	0.01	-0.01	0	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

122.6

111.51

82.46

67.34

Other Income

3.66

1.89

0.31

0.7

1.1

Stock Adjustments

-1.39

1.13

-0.99

-1.02

0.33

Total Income

124.87

114.53

81.78

67.02

79.43

EXPENDITURE :

Raw Materials

81.95

68.78

48.22

41.79

52.08

Excise Duty

0.06

0.21

Power and Fuel Cost

2.11

2.78

2.35

2.76

3.29

Other Manufacturing Expenses

5.95

8.67

5.39

3.3

3.2

Employee Cost

8.09

9.05

6.65

4.86

5.42

Selling and Administration Expenses

5.11

6.41

7.12

7.23

8.13

Miscellaneous Expenses

0.54

0.16

0.15

0.78

0.96

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

21.12

18.67

11.89

6.23

6.14

Interest and Financial Charges

1.38

2.71

3.61

3.62

3.92

Profit before Depreciation and Tax

19.74

15.96

8.28

2.61

2.22

Depreciation

2.21

2.06

1.92

1.9

2.1

Profit Before Tax

17.53

13.9

6.36

0.71

0.12

Tax

5.5

3.79

1.2

0.23

-0.32

Profit After Tax

12.03

10.11

5.16

0.48

0.44

Adjustment below Net Profit

-0.48

P and L Balance brought forward

19.74

10.96

5.32

5.36

Appropriations

1.33

P and L Bal. carried down

31.77

19.74

11.16

5.8

5.32

Equity Dividend

1.33

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

Earning Per Share (Rs.)

10.28

8.64

4.91

0.48

0.46

Book Value

74.05

63.77

24.73

17.92

17.77

Extraordinary Items

0.01

-0.01

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	11.7	11.7	10.52	9.99	9.51
Reserves and Surplus	74.93	62.91	16.26	7.92	7.67
Total Shareholders Funds	86.63	74.61	26.78	17.91	17.18
Secured Loans	11.63	14.39	16.55	18.27	20.72
Unsecured Loans	1.1	1.29	1.89	1.79	1.49
Total Debt	12.73	15.68	18.44	20.06	22.21
Total Liabilities	99.36	90.29	45.22	37.97	39.39
APPLICATION OF FUNDS :
Gross Block	46.58	45.78	37.66	35.79	34.94
Less: Accum. Depreciation	22.2	20.45	18.61	16.69	15.1
Net Block	24.38	25.33	19.05	19.1	19.84
Capital Work in Progress	14.76	0.28	0.45	0	0
Investments	0	0.07	0.07	0.02	0.02
Current Assets, Loans and Advances
Inventories	15.26	14.23	13.79	11.14	13.46
Sundry Debtors	43.37	38.42	25.69	16.09	26.51
Cash and Bank Balance	8.52	22.66	2.97	2.72	2.29
Loans and Advances	30.3	16.77	11.48	10.95	6.53
Less: Current Liab. and Prov.
Current Liabilities	31.64	23.2	26.81	21.51	29.15
Provisions	5.58	4.3	1.46	0.53	0.12
Net Current Assets	60.23	64.58	25.66	18.86	19.52
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	99.37	90.26	45.23	37.98	39.38
Contingent Liabilities	0	0	8.33	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

11.7

10.52

9.99

9.51

Reserves and Surplus

74.93

62.91

16.26

7.92

7.67

Total Shareholders Funds

86.63

74.61

26.78

17.91

17.18

Secured Loans

11.63

14.39

16.55

18.27

20.72

Unsecured Loans

1.1

1.29

1.89

1.79

1.49

Total Debt

12.73

15.68

18.44

20.06

22.21

Total Liabilities

99.36

90.29

45.22

37.97

39.39

APPLICATION OF FUNDS :

Gross Block

46.58

45.78

37.66

35.79

34.94

Less: Accum. Depreciation

22.2

20.45

18.61

16.69

15.1

Net Block

24.38

25.33

19.05

19.1

19.84

Capital Work in Progress

14.76

0.28

0.45

Investments

0.07

0.02

Current Assets, Loans and Advances

Inventories

15.26

14.23

13.79

11.14

13.46

Sundry Debtors

43.37

38.42

25.69

16.09

26.51

Cash and Bank Balance

8.52

22.66

2.97

2.72

2.29

Loans and Advances

30.3

16.77

11.48

10.95

6.53

Less: Current Liab. and Prov.

Current Liabilities

31.64

23.2

26.81

21.51

29.15

Provisions

5.58

4.3

1.46

0.53

0.12

Net Current Assets

60.23

64.58

25.66

18.86

19.52

Miscellaneous Expenses not w/o

Total Assets

99.37

90.26

45.23

37.98

39.38

Contingent Liabilities

8.33

MEDICAMEN BIOTECH LTD.

Enjoy Lifetime Free Delivery Trade